ARTICLE
15 August 2020

Webinar: Supplementary Protection Certificates - Part Two (Video)

D
Dehns

Contributor

Founded in 1920, Dehns is one of Europe’s largest full service intellectual property firms, with offices in London, Munich, Oslo, Oxford, Bristol, Brighton, Manchester and Birmingham.

In addition to obtaining patent, trade mark and design protection around the world, our services also extend to IP management consulting and dispute resolution. Dehns attorneys have expertise in a wide range of technologies across the engineering, chemistry and biotechnology sectors.

Our clients include private inventors, universities and research institutions, start-ups and SMEs as well as large multinational corporations. We are firmly focussed on delivering clear advice and valuable results at a competitive cost.

Dehns’ straightforward, business-oriented approach combined with technical excellence has made us leaders in our field and we are proud of our top tier rankings.

SPCs provide a valuable extension to patent protection in Europe for pharmaceutical, veterinary and plant protection products.
United Kingdom Intellectual Property

Hosted on 13 August 2020 by Chris Goddard, qualified European and UK patent attorney and a Partner at Dehns, this webinar is the second in a two part series on Supplementary Protection Certificates (SPCs).

SPCs provide a valuable extension to patent protection in Europe for pharmaceutical, veterinary and plant protection products.  

Following on from Chris' introduction to the SPC system in part 1, the second webinar takes an in depth look at the current "grey areas" of the SPC system.  Chris reviews some recent cases from the CJEU which consider what can be protected by an SPC and how far that protection extends.

Chris is a qualified European and UK patent attorney and a Partner at Dehns. He graduated from the University of Cambridge in with a degree in Natural Sciences (Chemistry) and was awarded a PhD, also by the University of Cambridge. He works for a variety of clients from sole-inventors and small biotech companies to multinational corporations. He works with inventions from a broad range of chemical technologies including organic chemistry, pharmaceuticals, drug delivery formulations, diagnostic assays, medical devices, solar cells and renewable energy. He provides patent drafting, filing, international prosecution and strategic IP portfolio advice and has experience in oppositions and appeals before the EPO.

Click here to hear about our upcoming webinars.

The information in this webinar is given as guidance only. Legal advice should be sought for particular matters. Dehns accepts no responsibility for any action taken / not taken on the basis of this webinar.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More